Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $103

Benzinga Newsdesk www.benzinga.com Negative 79.3%

Neg 79.3% Neu 0% Pos 0%

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $104 to $103.